Class I HDACs specifically regulate E‐cadherin expression in human renal epithelial cells

Epithelial‐mesenchymal transition (EMT) and renal fibrosis are closely involved in chronic kidney disease. Inhibition of histone deacetylase (HDAC) has an anti‐fibrotic effect in various diseases. However, the pathophysiological role of isoform‐specific HDACs or class‐selective HDACs in renal fibrosis remains unknown. Here, we investigated EMT markers and extracellular matrix (ECM) proteins in a human proximal tubular cell line (HK‐2) by using HDAC inhibitors or by knockdown of class I HDACs (HDAC1, 2, 3 and 8). Trichostatin A (TSA), MS275, PCI34051 and LMK235 inhibited ECM proteins such as collagen type I or fibronectin in transforming growth factor β1 (TGF‐β1)‐induced HK2 cells. However, restoration of TGF‐β1‐induced E‐cadherin down‐regulation was only seen in HK‐2 cells treated with TSA or MS275, but not with PCI34051, whereas TGF‐β1‐induced N‐cadherin expression was not affected by the inhibitors. ECM protein and EMT marker levels were prevented or restored by small interfering RNA transfection against HDAC8, but not against other class I HDACs (HDAC1, 2 and 3). E‐cadherin regulation is mediated by HDAC8 expression, but not by HDAC8 enzyme activity. Thus, class I HDACs (HDAC1, 2, 3 and 8) play a major role in regulating ECM and EMT, whereas class IIa HDACs (HDAC4 and 5) are less effective.

[1]  Hyung-Seok Kim,et al.  Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes. , 2015, Vascular pharmacology.

[2]  S. Park,et al.  HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. , 2015, Oncology reports.

[3]  S. Zhuang,et al.  Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling , 2013, PloS one.

[4]  H. Gohlke,et al.  Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. , 2013, Journal of medicinal chemistry.

[5]  E. Olson,et al.  Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development , 2012, Proceedings of the National Academy of Sciences.

[6]  L. Kenner,et al.  Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis , 2011, Cell cycle.

[7]  Jianguo Song,et al.  Histone deacetylase 1 is required for transforming growth factor-beta1-induced epithelial-mesenchymal transition. , 2010, The international journal of biochemistry & cell biology.

[8]  Merlin C. Thomas,et al.  The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology , 2010, Expert Reviews in Molecular Medicine.

[9]  S. Zhuang,et al.  Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. , 2009, American journal of physiology. Renal physiology.

[10]  Ji Yeon Seo,et al.  Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. , 2009, American journal of physiology. Renal physiology.

[11]  G. Wolf,et al.  TGF-beta and fibrosis in different organs - molecular pathway imprints. , 2009, Biochimica et biophysica acta.

[12]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[13]  Emily J. Greenspan,et al.  HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling , 2008, Cancer biology & therapy.

[14]  J. Lasky,et al.  Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition* , 2008, Journal of Biological Chemistry.

[15]  A. Leask TGFβ, cardiac fibroblasts, and the fibrotic response , 2007 .

[16]  Tiegang Liu,et al.  Smooth muscle α‐actin expression and myofibroblast differentiation by TGFβ are dependent upon MK2 , 2007 .

[17]  I. Adcock HDAC inhibitors as anti‐inflammatory agents , 2007, British journal of pharmacology.

[18]  Y. Shimono,et al.  Enhancer of Polycomb1, a Novel Homeodomain Only Protein-binding Partner, Induces Skeletal Muscle Differentiation* , 2007, Journal of Biological Chemistry.

[19]  M. Rastaldi Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. , 2006, Journal of nephrology.

[20]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.

[21]  J. Vieira,et al.  Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  Ricardo Macarron,et al.  Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases , 2003, Journal of Pharmacology and Experimental Therapeutics.

[23]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[24]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  J. Yamate,et al.  Macrophages, Myofibroblasts, and Extracellular Matrix Accumulation in Interstitial Fibrosis of Chronic Progressive Nephropathy in Aged Rats , 1998, Veterinary pathology.

[27]  M. Pichler,et al.  Epigenetic control of epithelial-mesenchymal-transition in human cancer. , 2013, Molecular and clinical oncology.

[28]  P. Kantharidis,et al.  The role of EMT in renal fibrosis , 2011, Cell and Tissue Research.

[29]  T. Fujita,et al.  Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. , 2007, Journal of the American Society of Nephrology : JASN.